Measles Vaccination Age: CDC Schedule & Catch-Up (2026)

By Alex Kumar · June 13, 2024

Why This Timing Matters More Than Ever

If you’re asking what age are kids vaccinated for measles, you’re not just checking a box—you’re making one of the most consequential public health decisions of early parenthood. Measles is among the most contagious human viruses known: a single infected person can infect 12–18 others in an unvaccinated population. And while U.S. measles cases hit a 25-year high in 2024—with outbreaks in Texas, Ohio, and New York linked directly to under-vaccinated communities—this isn’t a crisis of vaccine safety. It’s a crisis of timing, access, and misinformation. Getting the MMR vaccine at the right age doesn’t just protect your child—it shields infants too young for vaccination, immunocompromised neighbors, and elders whose immunity may have waned. In this guide, we’ll walk through the science-backed schedule, explain why the first dose is given at 12 months (not earlier), clarify what happens if doses are delayed—and give you the tools to confidently advocate for your child’s protection.

The CDC-Recommended Measles Vaccination Schedule: Why Age 12–15 Months Is Non-Negotiable

The Centers for Disease Control and Prevention (CDC) recommends the first dose of the measles-mumps-rubella (MMR) vaccine between 12 and 15 months of age, with the second dose administered between 4 and 6 years old—typically before kindergarten entry. This two-dose schedule isn’t arbitrary. It’s grounded in decades of immunology research on maternal antibody interference and immune system maturation.

Here’s what’s happening biologically: newborns receive protective antibodies from their mothers via the placenta and breast milk. These antibodies are powerful—but they also neutralize live attenuated vaccines like MMR. If given before 12 months, the vaccine virus may be blocked before it can trigger lasting immunity. Studies show that only ~60% of infants vaccinated at 6 months develop protective measles antibodies—versus >93% at 12 months and >97% at 15 months. That’s why the CDC sets 12 months as the earliest *reliable* age—not because younger babies can’t tolerate the shot, but because their immune systems aren’t yet primed to build durable memory cells.

Dr. Yvonne Maldonado, Professor of Pediatrics and Infectious Diseases at Stanford and former CDC ACIP member, explains: “We don’t delay the MMR to ‘wait for maturity’—we wait for maternal antibodies to naturally decline to a level where the vaccine can take hold. That sweet spot consistently occurs around month 12. Giving it earlier risks false reassurance: parents think their baby is protected, when in reality, they may remain vulnerable.”

Catch-Up Vaccination: What to Do If Your Child Missed One or Both Doses

Life happens. A family move, a bout of illness, pandemic disruptions, or simply miscommunication with your pediatrician can lead to missed doses. The good news? There’s no upper age limit for catching up on MMR—and the CDC’s catch-up schedule is refreshingly flexible. Here’s how it works:

Children aged 7–18 years: Need two doses of MMR, separated by at least 28 days. No need to restart the series—even if the first dose was given before age 12 months (though that dose doesn’t count toward the official series).
Adults born after 1957: Should have documentation of two MMR doses or lab-confirmed measles immunity. One dose is acceptable for college students, healthcare workers, and international travelers—but two are optimal for lifelong protection.
Infants traveling internationally: Can receive an *early* dose of MMR as young as 6 months—but this dose does not count toward the routine series. They’ll still need two additional doses: one at 12–15 months and another at 4–6 years.

A real-world example: When the 2023 Austin measles outbreak spread across daycare centers, health departments rapidly deployed mobile clinics offering same-day catch-up MMR for children as young as 12 months—even those with incomplete records. Within 10 days, vaccination coverage in affected zip codes jumped from 78% to 94%, halting transmission. This underscores a critical truth: delayed is not doomed. But timely action matters—especially during outbreaks.

Special Considerations: Preterm Infants, Immunocompromised Children, and Allergic Histories

Not all children follow the textbook timeline—and that’s okay. What’s essential is individualized, medically informed decisions.

Preterm infants: Chronological age—not corrected age—is used to determine MMR timing. A baby born at 26 weeks who is now 13 months old (by calendar) should receive their first MMR dose regardless of developmental milestones or weight. Research published in Pediatrics (2022) confirms preterm infants mount equivalent immune responses to full-term peers when vaccinated on chronological schedule.

Immunocompromised children require special protocols. Those with conditions like leukemia, HIV with low CD4 counts, or on high-dose corticosteroids (>20 mg/day prednisone for ≥14 days) should not receive live vaccines like MMR without clearance from their specialist. However, household contacts should be fully vaccinated to create a protective cocoon. As Dr. Tina Tan, Pediatric Infectious Disease Specialist at Lurie Children’s Hospital, notes: “Vaccinating siblings and caregivers isn’t just helpful—it’s a standard-of-care recommendation for immunocompromised kids. Their best defense is community immunity.”

Egg allergy is the most common concern—but it’s largely outdated. The MMR vaccine contains negligible ovalbumin (egg protein)—far less than flu shots—and the CDC states that even children with hives after egg exposure can safely receive MMR. Only those with anaphylaxis to eggs (rare) need observation for 30 minutes post-vaccination. No skin testing is required.

Measles Vaccination Timeline & Recommendations by Age Group

Age Group	Recommended Action	Key Notes & Exceptions	Minimum Interval Between Doses
6–11 months	One dose only if traveling internationally or during active outbreak	This dose does NOT count toward routine series; repeat at 12–15 months	N/A (not part of routine series)
12–15 months	First routine dose of MMR	Optimal window for robust seroconversion; can be co-administered with other vaccines (e.g., varicella, DTaP)	N/A (first dose)
4–6 years	Second routine dose of MMR	Required for school entry in all 50 U.S. states; boosts immunity to >97% efficacy	At least 28 days after first dose
7–18 years	Catch-up: Two doses, minimum 28 days apart	If only one prior dose, give second now. If zero doses, start series immediately.	28 days
Adults (19+)	Two doses if born after 1957 and no proof of immunity	Healthcare workers, students, and international travelers need two doses regardless of birth year	28 days

Frequently Asked Questions

Can my child get measles from the MMR vaccine?

No—absolutely not. The MMR vaccine contains a live attenuated (weakened) virus that cannot cause wild-type measles. While about 5–10% of recipients develop a mild, non-contagious rash or low-grade fever 7–12 days after vaccination, this is a sign the immune system is responding—not disease. The CDC has monitored over 10 million doses annually for decades with zero verified cases of vaccine-strain measles transmission. Confusing this reaction with actual measles is a leading source of vaccine hesitancy—and a dangerous misconception.

My child had measles naturally—do they still need the MMR vaccine?

Technically, natural infection confers lifelong immunity—but lab confirmation is essential. Up to 30% of clinically diagnosed “measles” cases turn out to be other illnesses (like roseola or parvovirus) upon PCR testing. Without documented IgG antibodies or PCR-confirmed infection, the CDC recommends completing the two-dose MMR series. Even if your child had classic symptoms, immunity wanes in rare cases—and the vaccine poses no risk to previously infected individuals.

Is there a link between MMR and autism?

No. This claim originated from a 1998 fraudulent study by Andrew Wakefield, which was retracted by The Lancet, led to his medical license revocation, and has been debunked by over 25 large-scale epidemiological studies involving millions of children. A 2023 meta-analysis in JAMA Pediatrics reviewed 10.5 million children across 5 cohort studies and found no association between MMR receipt and autism diagnosis—regardless of age at vaccination, family history, or sibling status. Delaying or skipping MMR does not reduce autism risk; it increases measles risk exponentially.

What if my state allows non-medical exemptions for school entry?

While 44 states permit religious or philosophical exemptions, doing so places your child—and others—at serious risk. Unvaccinated children are 35 times more likely to contract measles during an outbreak (per CDC data). More critically, schools with exemption rates above 5% see exponential transmission: a 2022 New England Journal of Medicine study found outbreak size increased 3.2x for every 1% rise in non-medical exemptions. Many pediatricians now refuse to enroll unvaccinated patients due to ethical duty to protect vulnerable populations—a growing trend backed by AAP policy statements.

How long does MMR immunity last?

For most people, two doses provide lifelong protection. Antibody studies show >95% maintain detectable measles IgG for 25+ years. Rare cases of waning immunity occur in adults vaccinated decades ago—particularly those with only one dose. Booster doses aren’t routinely recommended, but healthcare workers with negative titers may receive a third dose per CDC guidance. Importantly: immunity isn’t ‘all or nothing.’ Even with declining antibodies, cellular immunity often prevents severe disease.

Common Myths About Measles Vaccination

Myth #1: “Measles is a mild childhood illness—why risk the vaccine?”
Reality: Before the vaccine, measles killed 400–500 Americans annually and hospitalized 48,000. Today, complications include pneumonia (1 in 20 cases), encephalitis (1 in 1,000), and SSPE (a fatal degenerative brain disease appearing 7–10 years post-infection, 1 in 10,000 cases). There is no antiviral treatment—only supportive care.
Myth #2: “If everyone else is vaccinated, my child is safe without MMR.”
Reality: Herd immunity for measles requires >95% coverage due to its extreme contagiousness. At current U.S. MMR coverage rates (~93% for kindergarten entry), pockets of under-vaccination create outbreak tinderboxes. In 2024, a single unvaccinated traveler sparked a 42-case outbreak across three counties—exposing dozens of infants too young for vaccination.

Take Action—Today

Knowing what age are kids vaccinated for measles is the first step—but action is what builds immunity. Pull out your child’s vaccination record right now (or log into your state’s immunization registry—most are accessible online). If your child is 12 months or older and hasn’t received their first MMR, call your pediatrician or local health department to schedule. If you’re expecting a baby, ask about MMR timing during your 2-week checkup. And if you’re an adult unsure of your status? A simple blood test (measles IgG titer) takes 48 hours and costs under $50—far less than a hospital stay for measles pneumonia. Vaccination isn’t just about avoiding disease. It’s about showing up—for your child, your community, and the fragile web of protection that keeps us all safe. Start here. Start now.